Skip to main content
Top
Published in: Diabetologia 8/2020

01-08-2020 | Diabetic Retinopathy | Letter

Diabetic retinopathy: looking beyond the eyes

Authors: Rafael Simó, Coen D. A. Stehouwer, Angelo Avogaro

Published in: Diabetologia | Issue 8/2020

Login to get access

Excerpt

To the Editor: The eye as a tool for identifying systemic diseases has fascinated scientists for centuries. In the era of precision medicine, screening for diabetic retinopathy has emerged as a renewed cost-effective method, not only to prevent sight-threatening disease, but also to identify patients more prone to develop other diabetic complications [1, 2]. In recent years, evidence has accumulated indicating that diabetic retinopathy is not only a herald of microvascular complications, but also of macrovascular complications, such as ischaemic coronary disease and stroke [2, 3]. In addition, the presence of diabetic retinopathy is an independent risk factor for cognitive impairment and dementia and, consequently, is a useful tool to identify candidates for the screening of cognitive status [4]. …
Literature
1.
go back to reference Vujosevic S, Aldington SJ, Silva P et al (2020) Screening for diabetic retinopathy: new perspectives and challenges. Lancet Diabetes Endocrinol 8:337–347CrossRef Vujosevic S, Aldington SJ, Silva P et al (2020) Screening for diabetic retinopathy: new perspectives and challenges. Lancet Diabetes Endocrinol 8:337–347CrossRef
2.
go back to reference Pearce I, Simó R, Lövestam-Adrian M, Wong DT, Evans M (2019) Association between diabetic eye disease and other complications of diabetes: implications for care. A systematic review. Diabetes Obes Metab 21:467–478CrossRef Pearce I, Simó R, Lövestam-Adrian M, Wong DT, Evans M (2019) Association between diabetic eye disease and other complications of diabetes: implications for care. A systematic review. Diabetes Obes Metab 21:467–478CrossRef
3.
go back to reference Xie J, Ikram MK, Cotch MF et al (2017) Association of diabetic macular edema and proliferative diabetic retinopathy with cardiovascular disease: a systematic review and meta-analysis. JAMA Ophthalmol 135(6):586–593CrossRef Xie J, Ikram MK, Cotch MF et al (2017) Association of diabetic macular edema and proliferative diabetic retinopathy with cardiovascular disease: a systematic review and meta-analysis. JAMA Ophthalmol 135(6):586–593CrossRef
4.
go back to reference Simó R, Ciudin A, Simó-Servat O, Hernández C (2017) Cognitive impairment and dementia: a new emerging complication of type 2 diabetes—the diabetologist’s perspective. Acta Diabetol 54(5):417–424CrossRef Simó R, Ciudin A, Simó-Servat O, Hernández C (2017) Cognitive impairment and dementia: a new emerging complication of type 2 diabetes—the diabetologist’s perspective. Acta Diabetol 54(5):417–424CrossRef
5.
go back to reference Buse JB, Wexler DJ, Tsapas A et al (2020) 2019 update to: management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 63:221–228CrossRef Buse JB, Wexler DJ, Tsapas A et al (2020) 2019 update to: management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 63:221–228CrossRef
6.
go back to reference Simó R, Bañeras J, Hernández C et al (2019) Diabetic retinopathy as an independent predictor of subclinical cardiovascular disease: baseline results of the PRECISED study. BMJ Open Diabetes Res Care 7:e000845CrossRef Simó R, Bañeras J, Hernández C et al (2019) Diabetic retinopathy as an independent predictor of subclinical cardiovascular disease: baseline results of the PRECISED study. BMJ Open Diabetes Res Care 7:e000845CrossRef
7.
go back to reference Gerstein HC, Nair V, Chaube R et al (2019) Dysglycemia and the density of the coronary vasa vasorum. Diabetes Care 42:980–982CrossRef Gerstein HC, Nair V, Chaube R et al (2019) Dysglycemia and the density of the coronary vasa vasorum. Diabetes Care 42:980–982CrossRef
8.
go back to reference Sedding DG, Boyle EC, Demandt JAF et al (2018) Vasa vasorum angiogenesis: key player in the initiation and progression of atherosclerosis and potential target for the treatment of cardiovascular disease. Front Immunol 9:706CrossRef Sedding DG, Boyle EC, Demandt JAF et al (2018) Vasa vasorum angiogenesis: key player in the initiation and progression of atherosclerosis and potential target for the treatment of cardiovascular disease. Front Immunol 9:706CrossRef
9.
go back to reference Fadini GP, Albiero M, Bonora BM, Avogaro A (2019) Angiogenic abnormalities in diabetes mellitus: mechanistic and clinical aspects. J Clin Endocrinol Metab 104(11):5431–5444CrossRef Fadini GP, Albiero M, Bonora BM, Avogaro A (2019) Angiogenic abnormalities in diabetes mellitus: mechanistic and clinical aspects. J Clin Endocrinol Metab 104(11):5431–5444CrossRef
10.
go back to reference Simó R, Hernández C (2008) Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy. Diabetologia 51:1574–1580CrossRef Simó R, Hernández C (2008) Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy. Diabetologia 51:1574–1580CrossRef
11.
go back to reference Klein R, Sharret AR, Klein BEK et al (2002) The associations of atherosclerosis, vascular risks factors, and retinopathy in adults with diabetes: the Atherosclerosis Risk in Communities Study. Ophthalmology 109:1225–1234CrossRef Klein R, Sharret AR, Klein BEK et al (2002) The associations of atherosclerosis, vascular risks factors, and retinopathy in adults with diabetes: the Atherosclerosis Risk in Communities Study. Ophthalmology 109:1225–1234CrossRef
12.
go back to reference Barthelmes J, Nägele MP, Cantatore S et al (2019) Retinal microvascular dysfunction in patients with coronary artery disease with and without heart failure: a continuum? Eur J Heart Fail 21:988–997CrossRef Barthelmes J, Nägele MP, Cantatore S et al (2019) Retinal microvascular dysfunction in patients with coronary artery disease with and without heart failure: a continuum? Eur J Heart Fail 21:988–997CrossRef
13.
go back to reference Sundstrom JM, Hernández C, Weber SR et al (2018) Proteomic analysis of early diabetic retinopathy reveals mediators of neurodegenerative brain diseases. Invest Ophthalmol Vis Sci 59:2264–2227CrossRef Sundstrom JM, Hernández C, Weber SR et al (2018) Proteomic analysis of early diabetic retinopathy reveals mediators of neurodegenerative brain diseases. Invest Ophthalmol Vis Sci 59:2264–2227CrossRef
14.
go back to reference van Sloten TT, Sedaghat S, Carnethon MR, Launer LJ, Stehouwer CDA (2020) Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression. Lancet Diabetes Endocrinol 8(4):325–336CrossRef van Sloten TT, Sedaghat S, Carnethon MR, Launer LJ, Stehouwer CDA (2020) Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression. Lancet Diabetes Endocrinol 8(4):325–336CrossRef
15.
go back to reference Cheung N, Wang JJ, Klein R, Couper DJ, Sharret AR, Wong TY (2007) Diabetic retinopathy and the risk of coronary heart disease. Diabetes Care 30:1742–1746CrossRef Cheung N, Wang JJ, Klein R, Couper DJ, Sharret AR, Wong TY (2007) Diabetic retinopathy and the risk of coronary heart disease. Diabetes Care 30:1742–1746CrossRef
Metadata
Title
Diabetic retinopathy: looking beyond the eyes
Authors
Rafael Simó
Coen D. A. Stehouwer
Angelo Avogaro
Publication date
01-08-2020
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 8/2020
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-020-05195-4

Other articles of this Issue 8/2020

Diabetologia 8/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.